Biologics: Targets and Therapy
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.5 | Q2 | 69.6% | 0.989 | Q1 | 83.6% |
| 2024 | 3.4 | Q2 | 62.1% | 1.612 | Q1 | 93.1% |
| 2023 | 5.3 | Q1 | 80.1% | 1.276 | Q1 | 90.4% |
| 2022 | 4.0 | 63.5% | 1.176 | Q1 | 89.6% | |
| 2021 | — | 33.1% | 0.832 | Q2 | 82.2% | |
| 2020 | — | — | 0.948 | Q2 | 84.1% | |
| 2019 | — | — | 0.697 | Q2 | 76.8% | |
| 2018 | — | — | 0.683 | Q2 | 74.4% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1177-5475
ISSN
1177-5491
region
Pacific Region
coverage
1988, 2007-2026